Total Payments
$549,886
2024 Payments
$80,549
Companies
13
Transactions
364
Medicare Patients
243
Medicare Billing
$20,709
Payment Breakdown by Category
Consulting$379,835 (69.1%)
Travel$111,802 (20.3%)
Research$29,033 (5.3%)
Other$21,123 (3.8%)
Food & Beverage$8,061 (1.5%)
Education$32.27 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $379,835 | 112 | 69.1% |
| Travel and Lodging | $111,802 | 129 | 20.3% |
| Unspecified | $29,033 | 18 | 5.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,231 | 5 | 1.9% |
| Honoraria | $9,392 | 6 | 1.7% |
| Food and Beverage | $8,061 | 92 | 1.5% |
| Grant | $1,500 | 1 | 0.3% |
| Education | $32.27 | 1 | 0.0% |
Payments by Type
General
$520,854
346 transactions
Research
$29,033
18 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $266,623 | 132 | $0 (2024) |
| Novo Nordisk AS | $190,121 | 84 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $40,714 | 46 | $0 (2024) |
| Currax Pharmaceuticals LLC | $13,649 | 9 | $0 (2024) |
| Novo Nordisk Health Care AG | $12,315 | 7 | $0 (2019) |
| Regeneron Pharmaceuticals, Inc. | $11,292 | 18 | $0 (2024) |
| Eli Lilly and Company | $6,221 | 14 | $0 (2024) |
| PFIZER INC. | $4,553 | 4 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $4,114 | 9 | $0 (2017) |
| KVK-Tech, Inc. | $159.93 | 38 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $80,549 | 71 | Novo Nordisk Inc ($44,779) |
| 2023 | $92,925 | 52 | Novo Nordisk AS ($41,414) |
| 2022 | $59,351 | 37 | Novo Nordisk Inc ($27,418) |
| 2021 | $35,597 | 30 | Novo Nordisk AS ($17,742) |
| 2020 | $34,226 | 46 | Novo Nordisk AS ($16,738) |
| 2019 | $126,505 | 61 | Novo Nordisk Inc ($73,324) |
| 2018 | $64,244 | 31 | Novo Nordisk Inc ($35,530) |
| 2017 | $56,490 | 36 | Novo Nordisk AS ($27,199) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $209.58 | General |
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $39.68 | General |
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $39.68 | General |
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $31.75 | General |
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $31.75 | General |
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $370.03 | General |
| 11/13/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $7,218.75 | General |
| 11/13/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $653.14 | General |
| 11/13/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $530.75 | General |
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $508.28 | General |
| 11/13/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $362.19 | General |
| 11/12/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: Obesity | ||||||
| 11/04/2024 | Novo Nordisk AS | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $560.00 | General |
| 11/04/2024 | Novo Nordisk AS | — | Food and Beverage | In-kind items and services | $164.11 | General |
| 11/03/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| 10/10/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,290.00 | General |
| 10/10/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,860.00 | General |
| 10/10/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,430.00 | General |
| 10/10/2024 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $66.00 | General |
| 09/18/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| 09/03/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 09/03/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 08/29/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| EX9536-4388 | Novo Nordisk AS | $26,853 | 16 |
| HEOR OCMC | Novo Nordisk AS | $1,500 | 1 |
| NN9536-4373 | Novo Nordisk AS | $680.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 23 | 29 | $6,351 | $1,943 |
| 2022 | 3 | 61 | 71 | $17,337 | $5,722 |
| 2021 | 3 | 69 | 93 | $19,344 | $7,033 |
| 2020 | 4 | 90 | 104 | $20,480 | $6,011 |
Total Patients
243
Total Services
297
Medicare Billing
$20,709
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 29 | $6,351 | $1,943 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 41 | $8,979 | $2,974 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $5,208 | $1,558 | 29.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 17 | 18 | $3,150 | $1,189 | 37.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 51 | $11,169 | $3,994 | 35.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 25 | 31 | $5,425 | $2,018 | 37.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 11 | $2,750 | $1,021 | 37.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 45 | $9,855 | $2,281 | 23.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 28 | 31 | $5,425 | $1,820 | 33.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 16 | 16 | $4,000 | $1,437 | 35.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 11 | 12 | $1,200 | $472.96 | 39.4% |
About Dr. Robert Kushner, MD
Dr. Robert Kushner, MD is a Internal Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346278314.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Kushner, MD has received a total of $549,886 in payments from pharmaceutical and medical device companies, with $80,549 received in 2024. These payments were reported across 364 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($379,835).
As a Medicare-enrolled provider, Kushner has provided services to 243 Medicare beneficiaries, totaling 297 services with total Medicare billing of $20,709. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Chicago, IL
- Active Since 06/29/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346278314
Products in Payments
- Saxenda (Drug) $129,755
- Victoza (Drug) $31,316
- Wegovy (Drug) $24,333
- CONTRAVE (Drug) $13,649
- NASCOBAL (Drug) $4,114
- Ozempic (Drug) $1,000
- DAV-Arista AH (Device) $54.89
- NEXLIZET (Drug) $47.00
- PRALUENT ALIROCUMAB INJECTION (Biological) $12.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Chicago
Dr. Myles Wolf, Md, MD
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Dr. Merle Diamond, Md, MD
Internal Medicine — Payments: $1.4M
Internal Medicine $1.4M
Dr. Elizabeth Kiracofe, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Adam Stein, M.d, M.D
Internal Medicine — Payments: $503,325
Internal Medicine $503,325
Devalingam Mahalingam, M.d, M.D
Internal Medicine — Payments: $501,247
Internal Medicine $501,247
Dr. Romeo Ursua, M.d, M.D
Internal Medicine — Payments: $410,468
Internal Medicine $410,468